Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2025-12-25 @ 2:48 AM
NCT ID:
NCT03329833
Eligibility Criteria:
Inclusion Criteria:
* Community dwelling
* Age 18 or older
* Physician confirmed diagnosis of PD with Hoehn and Yahr stage ≤3
* Ability to ambulate independently (walker is allowed) for distance of 50 feet or 10 minutes at a time
* Does not meet current CDC physical activity guidelines of 150 minutes of moderate to vigorous physical activity per week
* Currently and plans to have a smartphone, tablet, or computer and access to the internet for the next 9 months
* Willing to monitor activity on their smartphone, tablet, or computer via a web-based application during the 9-month program
* Currently uses the internet in a basic capacity
Exclusion Criteria:
* Inability to speak and understand English
* Has a cardiovascular disorder or other health condition that would make exercise unsafe according to their physician
* Patients who are currently receiving physical therapy or received physical therapy one month prior to study enrollment
* Cognitive impairment as defined by inability to provide informed consent and to self-report feelings and behaviors
* Montreal Cognition Scale (MOCA): rating of less than 24, indicative of cognitive dysfunction
* Patients who indicate it is not recommended they participate in increased physical activity as indicated by the Physical Activity Restriction Questionnaire (PAR-Q)
* Patients who are in other studies that monitor fitness or physical activity
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03329833
Study Brief:
Protocol Section:
NCT03329833